SIRION BIOTECH GmbH is a biotech company that produces genetically modified cells and is a tech-nology provider in the area of viral vector systems for gene therapy and vaccine applications. The company was founded in 2006 and is located in Munich with offices in Tokyo and New Hampshire. The expert in RNAi technology offers a wide range of more than 100 products and services. Using state of the art techniques and assay systems the company offers reliable lead-through service pro-jects in target validation, screening and discovery for the drug, food & cosmetic industries.
SIRION BIOTECH currently operates projects for most of the major pharmaceutical companies in Europe and has ongoing collaborations with leading academic and governmental research institutes. Increasingly, clients from Japan and USA are being served.